CD24 targeting with NK‐CAR immunotherapy in testis, prostate, renal and (luminal‐type) bladder cancer and identification of direct CD24 interaction partners

癌症研究 CD24型 流式细胞术 活力测定 化学 CD44细胞 生物 细胞 免疫学 生物化学
作者
Christian Söhngen,David J. Thomas,Margaretha A. Skowron,Felix Bremmer,Markus Eckstein,Anja Stefanski,Marc D. Drießen,Gamal Anton Wakileh,Kai Stühler,Peter Altevogt,Dan Theodorescu,Rüdiger Klapdor,Axel Schambach,Daniel Nettersheim
出处
期刊:FEBS Journal [Wiley]
卷期号:290 (20): 4864-4876 被引量:3
标识
DOI:10.1111/febs.16880
摘要

Alternative therapeutic options targeting urologic malignancies, such as germ cell tumours, as well as urothelial, renal and prostate carcinomas, are still urgently needed. The membrane protein CD24 represents a promising immunotherapeutical approach. The present study aimed to decipher the molecular function of CD24 in vitro and evaluate the cytotoxic capacity of a third-generation natural killer (NK) cell chimeric antigen receptor (CAR) against CD24 in urologic tumour cell lines. Up to 20 urologic tumour cell lines and several non-malignant control cells were included. XTT viability assays and annexin V/propidium iodide flow cytometry analyses were performed to measure cell viability and apoptosis rates, respectively. Co-immunoprecipitation followed by mass spectrometry analyses identified direct interaction partners of CD24. Luciferase reporter assays were used to functionally validate transactivation of CD24 expression by SOX2. N- and O-glycosylation of CD24 were evaluated by enzymatic digestion and mass spectrometry. The study demonstrates that SOX2 transactivates CD24 expression in embryonal carcinoma cells. In cells of different urological origins, CD24 interacted with proteins involved in cell adhesion, ATP binding, phosphoprotein binding and post-translational modifications, such as histone acetylation and ubiquitination. Treatment of urological tumour cells with NK-CD24-CAR cells resulted in a decreased cell viability and apoptosis induction specifically in CD24+ tumour cells. Limitations of the study include the in vitro setting, which still has to be confirmed in vivo. In conclusion, we show that CD24 is a promising novel target for immune therapeutic approaches targeting urologic malignancies.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
dongxy发布了新的文献求助10
刚刚
yly发布了新的文献求助10
刚刚
plh完成签到,获得积分10
刚刚
阿梦发布了新的文献求助10
1秒前
1秒前
shi发布了新的文献求助10
1秒前
飞快的南安完成签到,获得积分10
1秒前
aomo完成签到 ,获得积分10
1秒前
zijian完成签到,获得积分10
2秒前
2秒前
可靠的幼荷完成签到,获得积分20
2秒前
2秒前
2秒前
HTT发布了新的文献求助20
2秒前
落寞明雪完成签到,获得积分10
3秒前
xgq发布了新的文献求助10
3秒前
orixero的应助被obtu采纳,获得10
3秒前
3秒前
rhy发布了新的文献求助10
3秒前
3秒前
巴爪鱼发布了新的文献求助30
3秒前
sunnymoon发布了新的文献求助10
4秒前
Maestro_S的应助被红娘采纳,获得10
4秒前
精明火车完成签到,获得积分20
4秒前
5秒前
风趣元珊完成签到,获得积分20
5秒前
xxy发布了新的文献求助10
5秒前
7秒前
7秒前
8秒前
折耳根拌香菜完成签到 ,获得积分10
8秒前
8秒前
小阿捡子完成签到,获得积分10
8秒前
9秒前
Anaturez完成签到,获得积分10
9秒前
瑾瑜发布了新的文献求助10
9秒前
9秒前
阿梦完成签到,获得积分10
10秒前
古炮发布了新的文献求助10
10秒前
康舟发布了新的文献求助10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161554
求助须知:如何正确求助?哪些是违规求助? 9556174
关于积分的说明 21732775
捐赠科研通 7751537
什么是DOI,文献DOI怎么找? 3427556
关于科研通互助平台的介绍 2552588
邀请新用户注册赠送积分活动 2472023